Cavion
Charlottesville, US · Founded 2016 · Delaware corporation
Biotech
Founders & leadership
AH
Anne HeldrethExecutive
AJ
Andrew J KrouseExecutive
TM
TIMOTHY MACDONALDNamed on SEC filing
LG
LLOYD GRAYNamed on SEC filing
AK
ANDREW KROUSENamed on SEC filing
Board
HS
Henry SkinnerBoard director
SP
Sergei PetukhovBoard director
SH
Steve HallBoard director
DE
David E GibsonBoard director
Reported raises · per SEC filings
Form D private placements$35.2M disclosed across 2 rounds · 2007–2016
▶$22.3MraisedJan 2017 · 19 investors · BiotechnologyRule 506(b)
▶$22.3MraisedJan 2017 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Henry SkinnerDirector
- Sergei PetukhovDirector
- Anne HeldrethExecutive Officer
- Steve HallDirector
- Andrew J KrouseExecutive Officer, Director
- David E GibsonDirector
- Offering amount
- $31.5M
- Amount sold
- $22.3M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$12.8MraisedJun 2014 · 54 investors · BiotechnologyRule 506(b)
▶$12.8MraisedJun 2014 · 54 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- TIMOTHY MACDONALDExecutive Officer
- LLOYD GRAYExecutive Officer
- ANDREW KROUSEExecutive Officer
- Amount sold
- $12.8M
- First sale
- Nov 2007
- Incorporated
- Limited Liability Company, Virginia
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Cavion raised?
- Cavion has disclosed $35.2M raised across 2 rounds.
- Where is Cavion headquartered?
- Cavion is headquartered in Charlottesville, US.